Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Research

| More

BSE Limited - Pricing pressure remains a challenge - ICICI Securities

Posted On: 2020-08-04 09:32:32


BSE Limited's (BSE) total revenues (operating + investment + dividend income) declined 2.2% YoY to Rs1.6bn with EBITDA margin at 29.5% (down 431bps YoY) and adjusted PAT down 13% YoY to Rs391mn in Q1FY21. BSE's cash segment witnessed a robust ADTO growth of 39%, but decline in exclusive segment turnover led to decline in transaction charges from equity segment. Mutual fund segment (80% market share within total orders in Q1FY21) continues to register strong growth (25% revenue growth in Q1FY21). The valuation of free cash and CDSL's 20% stake with a holding company discount of 20% limits the downside for the company; however, evolving pricing pressure in StAR MF platform remains an overhang. Post the run-up of 31% in stock price in past two months, we downgrade from Buy to ADD with a revised target price of Rs577 (earlier: Rs542).

- Contrary to our expectations, Q1FY21 exhibited positive momentum in cash ADTO and number of trades: The cash turnover for Q1FY21 was Rs2.2trn, a level last seen in Q1FY19. This was also supported by record number of cash trades (122mn) in Q1FY21. This spurt in cash volumes and relative outperformance over derivatives was a unique pattern observed in March-May and could be associated as a retail behavioural change during Covid. However, due to lower volumes in the exclusive segment, BSE's transaction revenues declined 13% in Q1FY21. Treasury income on C&S funds declined 7% YoY to Rs69mn, listing fees remained flat while book building fees were down 54% YoY, data dissemination charges fell 6% YoY and income from investment/deposit (Rs544mn) increased 11% on mark to market gains. EBITDA margin at 29.5% was down 431bps YoY. Q1FY21 adjusted PAT declined 13.3% YoY.

- Operating income outlook remains weak on account of pricing pressure: Transaction revenues witnessed a CAGR of (-) 0.8% in FY18-FY20 and we expect 2.6% CAGR between FY20-FY22E. Listing and book-building fees clocked 10.6% CAGR between FY18-FY20 and we expect this to be at 3.6% between FY20-FY22E. Operating income, which grew 6.4% between FY18-FY20, is expected to attain 2.9% CAGR between FY20-FY22E.

- Margins to decline in FY21E and recover in FY22E in line with Covid impact: Between FY18-FY20, revenues grew 2.1% while total operating expenses grew 8.7% resulting in sharp decline in EBITDA margin. We expect EBITDA margin to shrink to 20.4% in FY21E on account of lower revenue growth and recover to 27% in FY22E. Trailing 4-quarter revenue and EBITDA stands at Rs6.1bn and Rs1.4bn respectively vs our estimate of Rs6 bn and Rs1.2bn respectively.

- Cash contributes significantly to overall value. Total own cash (cash + investments - SGF - margin money) remains high (expected at ~Rs19.8bn by FY22E).

- StAR MF continues robust growth, pricing pressure remains an overhang: BSE processed 18.6mn orders on its mutual fund platform BSE StAR MF in Q1FY21, up 52% YoY. BSE earned Rs142mn (up 25% YoY) in transaction revenues from this segment in Q1FY21. Management decision to lower the rate per order will have an impact on FY21E/FY22E transaction revenues if the growth momentum in total orders slows down. BSE's market share in exchange-processed mutual fund transactions stood at a dominant ~80% in FY20.

- New initiatives remain possible, but growth drivers seem distant. ADTV and average daily number of orders traded on BSE-INX platform rose 2.9x and 3.5x in FY20. However, INX currently remains in the red with a loss of Rs230mn in FY20. Q1FY21 total turnover increased 8% due to introduction of currency derivatives. Insurance broking and EKYC businesses look promising, but without material contribution as of now. Interoperability results have been short of expectations

- Downgrade to ADD. We do an SoTP-based valuation of BSE as follows: (1) ~10x multiple to core earnings (excluding other income), (2) value BSE's 20% stake in CDSL at our target price (Rs354 per share) post a holding company discount of 20%, and (3) free cash of Rs19.8bn (Rs439/share) - to arrive at a target price of Rs577(earlier Rs542)


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Mazagon Dock IPO fully subscribed on Day 1 - Angel Broking

Pharma - Sector Thematic - Cardiac: the heartbeat of domestic market - HDFC Securities Institutional Research Desk

Walmart-Tata Retail Deal - Mr. Himanshu Nayyar, YES SECURITIES

HDFC Securities Institutional Research Desk: Chemical Conference Report

Lupin - Launch of Fosaprepitant - Angel Broking

Infosys - Key beneficiary of increased IT spending - Angel Broking

Gateway Distriparks - Holding structure simplified; prepared for next phase of growth - ICICI Securities

Visaka Industries - Demand and pricing tailwinds sustain; maintain a compelling BUY - ICICI Securities

GSK Pharmaceuticals - Analyst call highlights - Sep 28, 2020 - ICICI Securities

HeidelbergCement India - Play on better priced Central India; initiate with BUY - ICICI Securities

Healthcare - Diagnostics: Multiple tailwinds likely to emerge - ICICI Securities

Mazagon Dock Shipbuilders Ltd - IPO Review - ICICI Securities

Persistent Systems - 28th September 2020 - Angel Broking

Canara Bank - 28th September 2020 - Angel Broking

Subscribe to UTI Asset Management Company Limited - IPO Note - Angel Broking

Multiplex Sector - Mr. Jyoti Roy - DVP - Equity Strategist, Angel Broking Ltd

Sale of Sequent stake to Strides Pharma - Angel Broking

Subscribe to Mazagon Dock Shipbuilders Ltd - IPO Note - Angel Broking

JSW Energy - First big renewable step - ICICI Securities

V-MART Retail - Best play in value fashion segment; initiating with BUY - ICICI Securities

Gas sector - New winners and losers likely on policy changes in gas sector - ICICI Securities

Mazagon Dock Shipbuilders Limited - IPO Note - Geojit

UTI Asset Management Company Limited - IPO Note - Geojit

Preview on RBI Monetary Policy - Oct 2020 - Shanti Ekambaram

Rollover Report for September 2020 - October 2020: Angel Broking

Covid Recovery Pulse - Sep 25, 2020 - ICICI Securities

Quick Comment - Suven Pharmaceuticals - ICICI Securities

Derivatives Strategy - Sep 25, 2020 - Positional Option - ICICI Securities

Gladiator Stocks - Ramco Cement - ICICI Securities

IPO Review - UTI Asset Management Company - ICICI Securities

Stock of the Day - Zensar Technologies - Sep 25, 2020 - Angel Broking

Accenture Q4FY2020 Result - Angel Broking

Granules India receives ANDA approval - Angel Broking

Zydus Cadila receives US FDA approval - Angel Broking

Cipla - ANDA approval - Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

Mindspace REIT - Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

UTI AMC - IPO - Mr. Jaikishan Parmar - Sr. Equity Research Analyst, Angel Broking Ltd

Balkrishna Industries - Growth momentum continues - ICICI Securities

Rollover Analysis (September 25): Nifty starts October series with low OI amid high volatility

Derivatives View (September 25): Sell Bank Nifty in range of 20650-20750 - ICICI Securities

Rollover Analysis - Sept 20: Selling climax on expiry as markets crumble - YES Securities

Zydus Wellness - Leadership in niche categories; initiate at BUY - ICICI Securities

Power - Setting the stage - ICICI Securities

Company Update - Elgi Equipments - ICICI Securities

Nano Nivesh - The Anup Engineering - ICICI Securities

RBI OMO announcement of Rs. 10000 crore - Angel Broking

TCS deal win - Sep 24, 2020 - Angel Broking

View on Pre-Monetary Policy by Upasna Bhardwaj, Senior Economist at Kotak Mahindra Bank

US FDA approval to Zydus Cadila - Angel Broking

HDFC Securities Institutional Research Desk: Cement Sector Thematic - Spotting the sweet spot







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019